Accessibility Menu
VectivBio Ag logo

VectivBio Ag(NASDAQ) VECT

This security has been delisted. This page is retained for historical reference.

VectivBio Ag last closing stock price
MetricPriceDate
Last closeUSD 16.852023-07-07
VectivBio Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.12%USD 16.872023-06-30
1 month+1.08%USD 16.672023-06-07
3 month+84.96%USD 9.112023-04-06
Year to date+94.46%USD 8.672022-12-30
1 year+186.08%USD 5.892022-07-07
Since inception-30.46%USD 24.232021-04-09

VECT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

VECT Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-294.52%

Net Income Margin

-342.84%

Return on Equity

-56.92%

Return on Capital

-35.98%

Return on Assets

-37.11%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$27.34M

Operating Income

-$167.43M

EBITDA

-$166.54M

Operating Cash Flow

-$128.40M

Capital Expenditure

-$131.00K

Free Cash Flow

-$128.53M

Cash & ST Invst.

$221.42M

Total Debt

$10.46M

VectivBio Ag Performance Analysis

VectivBio Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 27,341,000N/A
VectivBio Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22021-06-30N/A
Q42021-12-31N/A
Q22022-06-30N/A
Q42022-12-31-97.5%
VectivBio Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -2.42N/A
20222022-12-31USD -2.12-12.2%
VectivBio Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22021-06-30-24.6%
Q42021-12-31N/A
Q22022-06-309.3%
Q42022-12-3155.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$676.00K

N/A

Gross Profit

$676.00K

N/A

Gross Margin

100.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$28.48M

+5.9%

EBITDA

-$28.54M

+3.7%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Total Cash

$221.42M

+451.1%

Total Debt

$10.46M

+8919.0%

Accounts Receivable

$1.43M

+48.5%

Inventory

-$1.43M

N/A

Long Term Debt

$10.33M

+258025.0%

Short Term Debt

$137.00K

+22.3%

Return on Assets

-37.11%

N/A

Return on Invested Capital

-35.34%

N/A

Free Cash Flow

$54.15M

+382.7%

Operating Cash Flow

$54.10M

+383.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRCLGracell Biotechnologies Inc.
$10.25+0.05%
ETHZEthzilla Corp.
$3.53+0.00%
VERVVerve Therapeutics, Inc.
$11.13+0.27%
EQRXEQRx, Inc.
$2.34-2.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
TAT&T
$24.13+0.05%
AALAmerican Airlines Group
$14.48+0.07%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.